1. Home
  2. OPBK vs ALXO Comparison

OPBK vs ALXO Comparison

Compare OPBK & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OP Bancorp

OPBK

OP Bancorp

HOLD

Current Price

$14.32

Market Cap

213.9M

Sector

Finance

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.49

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPBK
ALXO
Founded
2005
2015
Country
United States
United States
Employees
249
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.9M
240.8M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
OPBK
ALXO
Price
$14.32
$1.49
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$16.50
$3.50
AVG Volume (30 Days)
29.2K
1.4M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.73%
N/A
EPS Growth
23.74
26.36
EPS
0.48
N/A
Revenue
$3,204,000.00
N/A
Revenue This Year
$16.07
N/A
Revenue Next Year
$11.60
N/A
P/E Ratio
$29.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$0.41
52 Week High
$15.27
$2.66

Technical Indicators

Market Signals
Indicator
OPBK
ALXO
Relative Strength Index (RSI) 56.38 41.31
Support Level $13.63 $1.37
Resistance Level $14.95 $1.59
Average True Range (ATR) 0.37 0.12
MACD 0.02 -0.02
Stochastic Oscillator 72.28 30.77

Price Performance

Historical Comparison
OPBK
ALXO

About OPBK OP Bancorp

OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: